NuCana Plc (NCNA)
2.10
-0.04
(-2.10%)
USD |
NASDAQ |
Feb 20, 16:00
2.10
0.00 (0.00%)
Pre-Market: 20:00
NuCana SG&A Expense (Quarterly) : 1.886M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | 36.05M |
| Mereo BioPharma Group Plc | 6.007M |
| Bicycle Therapeutics Plc | 18.74M |
| DBV Technologies SA | 8.399M |